Location History:
- Munchen, DE (1999)
- München, DE (2001 - 2003)
Company Filing History:
Years Active: 1999-2003
Title: **The Innovative Mind of Hans-Jochem Kolb**
Introduction
Hans-Jochem Kolb, a notable inventor based in München, Germany, has made significant contributions to the field of biotechnology. With a focus on the development of bi- and trispecific antibodies, Kolb’s innovative research has resulted in three patented inventions that aim to enhance anti-tumor immunity.
Latest Patents
Kolb's latest patents demonstrate his dedication to advancing cancer treatment methodologies. One prominent patent titled "Bi-and trispecific antibodies for the induction of anti-tumor immunity" outlines a method utilizing intact bispecific or trispecific antibodies. This innovative approach targets the T cell receptor complex of a T cell, tumor-associated antigens on a tumor cell, and binds to Fc receptor-positive cells to promote anti-tumor immunity in both humans and animals.
Another significant patent, “Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies,” details a procedure for the ex vivo destruction of contaminating tumor cells in stem cell transplants using intact bispecific antibodies, showcasing Kolb’s commitment to improving stem cell therapies.
Career Highlights
Kolb is affiliated with the GSF-Forschungszentrum für Umwelt und Gesundheit, GmbH, where he has been instrumental in pioneering research aimed at combating cancer through innovative therapeutic strategies. His work has led to groundbreaking advancements in the intersection of immunology and oncology.
Collaborations
Throughout his career, Kolb has collaborated with esteemed colleagues such as Horst Lindhofer and Stefan Thierfelder. These partnerships have fostered an environment of innovation, driving forward the research and development of novel therapeutic agents aimed at enhancing cancer treatment.
Conclusion
Hans-Jochem Kolb's inventive spirit and dedication to cancer research underscore his importance in the biotechnology field. Through his innovative patents and collaborative efforts, Kolb continues to impact the scientific community positively, paving the way for breakthroughs that could change the lives of many affected by cancer.